Medivation, Inc.

Press Releases

Company News
View Summary Medivation Announces Participation at Upcoming Investor Conference
Aug 25, 2014
PDF 9.6 KB Add to Briefcase
View Summary Medivation Reports Second Quarter Financial Results and Provides Corporate Update
Aug 7, 2014
PDF 77.3 KB Add to Briefcase
View Summary Medivation Announces Second Quarter 2014 Financial Results Teleconference on August 7, 2014
Jul 24, 2014
PDF 9.0 KB Add to Briefcase
View Summary Medivation Announces Change in Executive Management Team
Jul 10, 2014
PDF 55.7 KB Add to Briefcase
View Summary Medivation Again Voted Among Top Workplaces in the SF Bay Area
Jun 16, 2014
PDF 11.0 KB Add to Briefcase
View Summary Medivation Founder, President and Chief Executive Officer David Hung, M.D. Named an EY Entrepreneur Of The Year(TM) 2014 Award Winner in Northern California
Jun 11, 2014
PDF 11.1 KB Add to Briefcase
View Summary New England Journal of Medicine Publishes Results From Phase 3 PREVAIL Trial of Enzalutamide in Men With Chemotherapy-Naive Metastatic Prostate Cancer Progressing Despite Androgen Deprivation Therapy
Jun 1, 2014
PDF 62.1 KB Add to Briefcase
View Summary Enzalutamide Data, Including Additional Results From the PREVAIL Trial, to Be Presented at Upcoming ASCO Annual Meeting
May 14, 2014
PDF 60.9 KB Add to Briefcase
View Summary Medivation Announces Participation at Upcoming Investor Conferences
May 12, 2014
PDF 9.5 KB Add to Briefcase
View Summary Medivation Reports First Quarter Financial Results and Provides Corporate Update
May 8, 2014
PDF 76.4 KB Add to Briefcase
View Summary Astellas and Medivation Receive Priority Review From FDA for XTANDI(R) (Enzalutamide) Capsules in Chemotherapy-Naive Advanced Prostate Cancer
May 6, 2014
PDF 57.1 KB Add to Briefcase
View Summary Medivation Announces First Quarter 2014 Financial Results Teleconference on May 8, 2014
Apr 24, 2014
PDF 9.0 KB Add to Briefcase
View Summary Medivation Enters Into License Agreement With OncoFusion for Compounds Targeting Bromodomain Proteins
Apr 23, 2014
PDF 12.7 KB Add to Briefcase
View Summary Medivation Appoints Patrick Machado to Board of Directors
Apr 17, 2014
PDF 9.4 KB Add to Briefcase
View Summary Astellas Announces European Regulatory Submission For XTANDI® (enzalutamide) Capsules For Chemotherapy-Naive Metastatic Prostate Cancer
Apr 3, 2014
PDF 56.5 KB Add to Briefcase
View Summary Medivation Names Rick Bierly Chief Financial Officer
Mar 31, 2014
PDF 9.9 KB Add to Briefcase
View Summary Astellas and Medivation Submit Supplemental New Drug Application for XTANDI (Enzalutamide) for Chemotherapy-Naive Advanced Prostate Cancer
Mar 18, 2014
PDF 56.7 KB Add to Briefcase
View Summary Medivation Reports Fourth Quarter and Year-End 2013 Financial Results and Provides Corporate Update
Feb 27, 2014
PDF 77.1 KB Add to Briefcase
View Summary Medivation Announces Fourth Quarter and Year-End 2013 Financial Results Teleconference on February 27, 2014
Feb 10, 2014
PDF 9.2 KB Add to Briefcase
View Summary Medivation Announces Participation at Upcoming Investor Conference
Jan 31, 2014
PDF 9.4 KB Add to Briefcase
Showing 1-20 of 303 Page: 1 2 3 4 5 ... 16  Next 20
Add to Briefcase = add release to Briefcase